Patent · US Active

Pyridazinone macrocycles as IRAK inhibitors and uses thereof

US9624246B2 · kind B2 · utility

7Cited by
0References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 5, 2016
Grant dateApr 18, 2017
Priority date
Expiry dateFeb 5, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/22
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds of Formula I and pharmaceutically acceptable compositions thereof, useful as IRAK inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.